Press Release Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe 24 May 2024
Press Release CMBM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cambium Networks Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! 24 May 2024
Press Release Hagens Berman and Winston & Strawn Secure Historic Multibillion-Dollar Settlement for College Athletes and Bring Revolutionary Change to College Sports 24 May 2024
Press Release Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors 23 May 2024
Press Release BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! 23 May 2024
Press Release FDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option 23 May 2024
Press Release Browning West Announces Successful Replacement of Gildan Activewear’s Entire Board of Directors with Full Eight-Member Slate 23 May 2024
